首页> 外文期刊>Journal of Neuropathology and Experimental Neurology: Official Journal of the American Association of Neuropathologists, Inc >The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
【24h】

The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.

机译:p15(INK4b)/ p16(INK4a)/ RB1途径在人垂体腺瘤中经常失控。

获取原文
获取原文并翻译 | 示例
       

摘要

Pituitary adenomas are common benign intracranial neoplasms. However, their tumorigenesis is not yet clearly defined. Inactivation of genes involved in the negative cell-cycle regulatory p15(INK4b) - p16(INK4a) -cyclin D/CDK4-RB1-mediated pathway (RB1 pathway) is one of the most common and important mechanisms in the growth advantage of tumor cells. Recently, much attention has been focused on the importance of alternative mechanisms of gene inactivation, particularly promoter hypermethylation in the transcriptional silencing of such tumor-suppressor genes. Based on the rare occurrence of inactivation by gene mutations and deletions of the RB1 pathway in pituitary adenomas, we investigated the deregulation of the RB1 pathway in 42 sporadic human pituitary adenomas, especially focusing on the methylation status of this pathway as determined by a methylation-specific polymerase chain reaction assay. Homozygous deletion of the p15(INK4b) or p16(INK4a) gene was detected in one adenoma each. Amplification of the CDK4 gene was not apparent in any of the pituitary adenomas presently examined. Promoter hypermethylation of the p15(INK4b), p16(INK4a), and RB1 genes was detected in 15 (35.7%), 30 (71.4%), and 12 (28.6%) of the adenomas, respectively. Promoter hypermethylation of the p15(INK4b) gene coincided with p16(INK4a) alteration and/or RB1 methylation, whereas p16(INK4a) and RB1 methylations tended to be mutually exclusive (p = 0.019). Thus, the vast majority of the adenomas (38 of 42, 90.5%) displayed alterations of the RB1 pathway. None of the clinicopathologic features, including the proliferation cell index, was significantly correlated with any particular methylation status. Our results suggest that inactivation of the RB1 pathway may play a causal role in pituitary tumorigenesis, with hypermethylation of the p16(INK4a) gene being the most common deregulation, and further provide evidence that RB1 and p16(INK4a) methylations tend to be mutually exclusive but occasionally coincide with p15(INK4b) methylation.
机译:垂体腺瘤是常见的良性颅内肿瘤。然而,它们的肿瘤发生作用尚未明确定义。负细胞周期调控p15(INK4b)-p16(INK4a)-cyclin D / CDK4-RB1介导的途径(RB1途径)涉及的基因失活是肿瘤细胞生长优势中最常见和重要的机制之一。近来,许多注意力集中在基因失活的替代机制的重要性上,特别是在这种肿瘤抑制基因的转录沉默中启动子高甲基化。基于垂体腺瘤中基因突变和RB1途径缺失导致的失活很少发生,我们研究了42例散发性人垂体腺瘤中RB1途径的失调,特别是研究了该途径的甲基化状态(由甲基化决定-特异性聚合酶链反应分析。在一个腺瘤中分别检测到p15(INK4b)或p16(INK4a)基因的纯合缺失。 CDK4基因的扩增在目前检查的任何垂体腺瘤中都不明显。在15例腺瘤(35.7%),30例腺瘤(71.4%)和12例腺瘤(28.6%)中检测到了p15(INK4b),p16(INK4a)和RB1基因的启动子甲基化。 p15(INK4b)基因的启动子高甲基化与p16(INK4a)改变和/或RB1甲基化同时发生,而p16(INK4a)和RB1甲基化则倾向于互斥(p = 0.019)。因此,绝大多数腺瘤(42例中的38例,90.5%)表现出RB1通路的改变。包括增殖细胞指数在内的任何临床病理特征均未与任何特定的甲基化状态显着相关。我们的结果表明,RB1途径的失活可能在垂体肿瘤发生中起因果作用,其中最常见的解除调节是p16(INK4a)基因的甲基化,进一步证明RB1和p16(INK4a)甲基化往往互斥但偶尔与p15(INK4b)甲基化相吻合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号